Spyre Therapeutics SYRE
NASDAQ SYRE
$106.82 +2.34 (+2.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Spyre Therapeutics (SYRE) Revenue (2017 - 2023)

Updated

Analysis

Spyre Therapeutics (SYRE) Revenue (2017 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Spyre Therapeutics 9.40 Bn 5.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 688,000.00
Mar 31, 2023 198,000.00
Dec 31, 2022 168,000.00
Sep 30, 2022 174,000.00
Jun 30, 2022 625,000.00
Mar 31, 2022 1.36 Mn
Dec 31, 2021 3.64 Mn
Sep 30, 2021 1.40 Mn
Jun 30, 2021 13.70 Mn
Jun 30, 2018 2.38 Mn
Mar 31, 2018 1.51 Mn
Dec 31, 2017 1.48 Mn
Sep 30, 2017 1.26 Mn
Jun 30, 2017 1.48 Mn
Mar 31, 2017 982,000.00
API Access

Spyre Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SYRE&period=max&api_key=YOUR_API_KEY